BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com

Analysts at StockNews.com initiated coverage on shares of BIOLASE (NASDAQ:BIOL) in a report released on Thursday. The brokerage set a “sell” rating on the medical technology company’s stock.

Other equities research analysts also recently issued reports about the company. Benchmark reaffirmed a “speculative buy” rating and set a $0.40 price target on shares of BIOLASE in a research note on Wednesday, October 2nd. Ascendiant Capital Markets cut their price target on BIOLASE from $3.50 to $2.00 and set a “buy” rating for the company in a research note on Tuesday, September 3rd.

BIOLASE Stock Performance

Shares of BIOLASE stock opened at $0.01 on Thursday. The stock has a 50-day moving average price of $0.02 and a 200 day moving average price of $0.07. The company has a market cap of $200,442.00, a P/E ratio of 0.00 and a beta of 0.67. BIOLASE has a 1 year low of $0.02 and a 1 year high of $1.94.

Institutional Inflows and Outflows

An institutional investor recently raised its position in BIOLASE stock. Virtu Financial LLC raised its holdings in shares of BIOLASE, Inc. (NASDAQ:BIOL) by 1,068.0% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 143,537 shares of the medical technology company’s stock after buying an additional 131,248 shares during the quarter. Virtu Financial LLC owned about 0.43% of BIOLASE worth $27,000 as of its most recent SEC filing. 8.79% of the stock is currently owned by institutional investors.

BIOLASE Company Profile

BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.